Page last updated: 2024-11-05

phenyl isocyanate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID7672
CHEBI ID53806
SCHEMBL ID5925
MeSH IDM0084518

Synonyms (61)

Synonym
karbanil [czech]
ai3-28250
fenylisokyanat [czech]
hsdb 5356
einecs 203-137-6
nsc 74454
un2487
isocyanic acid, phenyl ester
nsc-74454
mondur p
phenylcarbimide
phenyl carbonimide
carbanil
nsc74454
wln: ocnr
benzene,isocyanate
benzene, isocyanato-
phenyl isocyanate ,
103-71-9
isocyanatobenzene
inchi=1/c7h5no/c9-6-8-7-4-2-1-3-5-7/h1-5
phenyl isocyanate, >=98%
phnco
CHEBI:53806 ,
AKOS000119300
A800789
phenylisocyanate
fenylisokyanat
karbanil
ec 203-137-6
196go6bsoh ,
phenyl isocyanate [un2487] [poison]
unii-196go6bsoh
BBL013184
isocyanato-benzene
isocyanic acid phenyl ester
I0131
STL163963
phenyl isocyanate, 14c-labeled cpd
EPITOPE ID:117716
phenyl isocyanate [mi]
phenyl isocyanate [hsdb]
SCHEMBL5925
phenyl isocynate
4-isocyanatobenzene
1-isocyanatobenzene
isocyanato benzene
phenyl-isocyanate
DTXSID5051521
phenyl ester of isocyanic acid
un 2487
J-523933
phenyl socyanate
phenyl isocyanate, for hplc derivatization, >=99.0% (gc)
phenyl isocyanate, technical, >=98.0% (gc)
phenyl isocyanate, p.a., 99.5%
isocyanate, phenyl ester
1,2-diacylglycerol-ld-pi-pool
carba0
Q408413
EN300-21290

Research Excerpts

Overview

Phenyl isocyanate is a highly reactive compound. It is used as a reagent in organic synthesis and in the production of polyurethanes.

ExcerptReferenceRelevance
"Phenyl isocyanate is a highly reactive compound that is used as a reagent in organic synthesis and in the production of polyurethanes. "( Novel glutathione conjugates of phenyl isocyanate identified by ultra-performance liquid chromatography/electrospray ionization mass spectrometry and nuclear magnetic resonance.
Åstot, C; Johansson Mali'n, T; Lindberg, S, 2014
)
2.13

Dosage Studied

ExcerptRelevanceReference
" Using an identical dosing regimen, parallel results were observed in the effects of these isothiocyanates on O6-methylguanine formation in the lung, in which PEITC at either dose resulted in considerable inhibition at 2 or 6 h after NNK administration, while BITC or PITC had little effect."( Effects of aromatic isothiocyanates on tumorigenicity, O6-methylguanine formation, and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung.
Amin, SG; Chung, FL; Hecht, SS; Morse, MA, 1989
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
haptenAny substance capable of eliciting an immune response only when attached to a large carrier such as a protein. Examples include dinitrophenols; oligosaccharides; peptides; and heavy metals.
allergenA chemical compound, or part thereof, which causes the onset of an allergic reaction by interacting with any of the molecular pathways involved in an allergy.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
isocyanatesOrganonitrogen compounds that are derivatives of isocyanic acid; compounds containing the isocyanate functional group -N=C=O (as opposed to the cyanate group, -O-C#N).
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (41)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (29.27)18.7374
1990's7 (17.07)18.2507
2000's11 (26.83)29.6817
2010's8 (19.51)24.3611
2020's3 (7.32)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.26

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.26 (24.57)
Research Supply Index3.81 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index69.41 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.26)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.27%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other43 (97.73%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]